To confirm endogenous MCP-1 expression within the HNSCC microenvironment, tissue sections from 15 HNSCC biopsies were stained using antibodies specific for MCP-1 and two unique chemoattractant ligands (MDC and TARC) for CCR4 (Figure 4E). The gene discussed is CCL22; the disease is head and neck squamous cell carcinoma.